Indian drugmaker Mankind Pharma reported a lower first-quarter profit on Thursday, as mounting expenses outpaced strong ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.

Psyence Biomedical Ltd. (Nasdaq: PBM) ('Psyence BioMed” or the 'Company”) is pleased to announce that its strategic partner, PsyLabs - a leader in the production of purified psychedelic compounds - ...

The Drug Enforcement Administration is warning Gen X and Millennial parents about how kids could be using scrunchies.

Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat is required for inhibition of aldosterone synthesis than for inhibition of ...

As US President Donald Trump announces a 25% tariff on India, Chief Economist of Infomerics Ratings Manoranjan Sharma said, ...

India will face steep tariffs of up to 25 per cent as trade talks with Washington stall ahead of the August 1 deadline set by ...

President Donald Trump announced a new trade agreement with the European Union on Sunday, halving steep tariffs but ...